Ionis Pharmaceuticals, Inc. (IONS)
27.31
-1.02
(-3.60%)
USD |
NASDAQ |
Nov 12, 16:00
27.38
+0.07
(+0.26%)
After-Hours: 07:32
Ionis Pharmaceuticals Total Liabilities (Quarterly) : 2.519B for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 2.519B |
| June 30, 2026 | 2.555B |
| March 31, 2026 | 2.959B |
| December 31, 2025 | 3.035B |
| September 30, 2025 | 2.415B |
| June 30, 2025 | 2.353B |
| March 31, 2025 | 2.337B |
| December 31, 2024 | 2.415B |
| September 30, 2024 | 2.419B |
| June 30, 2024 | 2.427B |
| March 31, 2024 | 2.467B |
| December 31, 2023 | 2.603B |
| September 30, 2023 | 2.619B |
| June 30, 2023 | 2.543B |
| March 31, 2023 | 2.399B |
| December 31, 2022 | 1.961B |
| September 30, 2022 | 1.828B |
| June 30, 2022 | 1.831B |
| March 31, 2022 | 1.810B |
| December 31, 2021 | 1.840B |
| September 30, 2021 | 1.884B |
| June 30, 2021 | 1.914B |
| March 31, 2021 | 1.568B |
| December 31, 2020 | 1.646B |
| September 30, 2020 | 1.489B |
| Date | Value |
|---|---|
| June 30, 2020 | 1.484B |
| March 31, 2020 | 1.521B |
| December 31, 2019 | 1.549B |
| September 30, 2019 | 1.397B |
| June 30, 2019 | 1.421B |
| March 31, 2019 | 1.448B |
| December 31, 2018 | 1.481B |
| September 30, 2018 | 1.408B |
| June 30, 2018 | 1.430B |
| March 31, 2018 | 912.46M |
| December 31, 2017 | 957.49M |
| September 30, 2017 | 854.89M |
| June 30, 2017 | 875.26M |
| March 31, 2017 | 882.19M |
| December 31, 2016 | 812.90M |
| September 30, 2016 | 703.95M |
| June 30, 2016 | 699.90M |
| March 31, 2016 | 717.66M |
| December 31, 2015 | 755.32M |
| September 30, 2015 | 742.59M |
| June 30, 2015 | 675.94M |
| March 31, 2015 | 679.58M |
| December 31, 2014 | 698.03M |
| September 30, 2014 | 449.03M |
| June 30, 2014 | 450.92M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 4.391B |
| BridgeBio Pharma, Inc. | 3.815B |
| Biogen, Inc. | 13.13B |
| Ultragenyx Pharmaceutical, Inc. | 1.556B |
| Krystal Biotech, Inc. | 150.47M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.913B |
| Shareholders Equity (Quarterly) | 393.64M |
| Debt to Equity Ratio | 5.520 |
| Current Ratio | 5.425 |
| Net Debt Paydown Yield | -0.53% |